Tag: entrepreneurs
-
Immunotherapy Start-Up Adds $134M in Venture Funding
5 August 2014. Juno Therapeutics, a biotechnology company in Seattle developing cancer treatments that harness the human immune system, secured $134 million in its second round of venture financing. The company, a spin-off enterprise from research labs in Seattle and New York, says the new round was provided by 10 public mutual funds and health…
-
Allied Minds, Bristol-Myers Squibb Form Life Science Venture
4 August 2014. Allied Minds, a research commercialization company in Boston, and the pharmaceutical company Bristol-Myers Squibb in New York are starting a joint venture to discover new drug candidates and enterprises from promising life science research in U.S. university labs. Financial terms of the new venture, named Allied-Bristol Life Sciences LLC, were not disclosed.…
-
U.S. Patent Awarded for Prodrug Cancer Imaging, Treatment
30 July 2014. A new patent was awarded for a technology that detects and treats solid tumor cancers with a prodrug, a precursor compound activated inside the body — made by GenSpera Inc., a biotechnology company in San Antonio. U.S. patent number 8,772,226 was awarded on 8 July to inventors Samuel Denmeade and John Isaacs…
-
Cancer Screening Blood Test Proposed, New Company Formed
28 July 2014. A team from University of Bradford in the U.K. developed a simple blood test, which in early tests suggests it could screen patients for common types of cancer. The researchers led by medical sciences professor Diana Anderson published their findings last Friday in FASEB Journal, published by Federation of American Societies for…
-
Organ Chip Start-Up Gains $12 Million in Early Funds
28 July 2014. Emulate Inc., a new company spun-off from a Harvard University bioengineering lab, raised $12 million in its first venture round to finance development of chip-like devices that mimic the functions of human organs. The funding round was led by NanoDimension, a venture capital company specializing in nanotechnologies, with Cedars-Sinai Medical Center and…
-
Spin-Off Company Developing Cardiac Drug Tests
22 July 2014. A medical researcher at Coventry University in the U.K. is spinning-off a new company to commercialize her research on cardiac drug toxicity for screening new therapies for dangerous side effects before testing on patients. Helen Maddock, a lecturer in cardiovascular physiology and pharmacology, is starting InoCardia to provide this service to pharmaceutical…
-
Chip Device Developed to Quickly Test for Type 1 Diabetes
14 July 2014. Medical researchers at Stanford University in California invented a small, handheld microchip that more quickly and easily tests for type 1 diabetes than current methods. The team led by Stanford pediatric endocrinologist Brian Feldman published its results online yesterday in the journal Nature Medicine (paid subscription required). They are also starting a…
-
Panel: Federal Science Cuts Hurt U.S. Competitiveness
9 July 2014. A panel of research executives from 10 universities in the U.S. told of the harmful impact of Federal spending cuts on science in the past few years, which the panelists said reduces the country’s ability to compete in world markets. The roundtable discussion at the National Press Club in Washington, D.C. was…
-
Solar Process Converts CO2 to Source of Power, Chemicals
2 July 2014. Chemists from Princeton University and spin-off company Liquid Light Inc. in Monmouth Junction, New Jersey created a process to use sunlight for converting carbon dioxide into formic acid, a source for electric power and industrial chemicals. Princeton chemistry professor Andrew Bocarsly, also a founder of Liquid Light, and colleagues published their findings…
-
Spin-Off Licenses Genomic Technology from Wash. University
30 June 2014. PierianDx, a new company formed by medical faculty and practitioners at Washington University in St. Louis, licensed genomic technology from the university to commercialize diagnostic tools for personalized medicine. Financial details of the licensing deal were not disclosed. The start-up company plans to offer the technology in a system developed internally by…